AzTrials
AzTrials

Post-Traumatic Growth, PsychologicalNCT02940028

ICU Experience in Family Members

A study testing Expressive writing in people with Post-Traumatic Growth, Psychological, run by Intermountain Health Care, Inc. at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The ICU is a stressful and challenging place for patients and their families. Many family members experience anxiety, depression, and post-traumatic stress disorder during and after their ICU experience. The investigators are studying post-traumatic growth in this study. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Post-Traumatic Growth, Psychological
What is being tested?
Expressive writing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
1 siteUnited States
Study dates
29 Apr 2017to Apr 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Family members of ICU patients are eligible for the study. We will enroll one study participant per patient admitted to a study ICU (Shock Trauma or Respiratory ICU at Intermountain Medical Center) who meets the following inclusion criteria:
  • Participant can be a family member of a patient admitted to a study ICU for >24 hours and ≥1 of the following:
  • mechanical ventilation via endotracheal tube for ≥ 12 hours
  • non-invasive ventilation (CPAP, BiPAP) for > 4 hours in a 24-hour period provided for acute respiratory failure in an ICU (not for obstructive sleep apnea or other stable use)
  • high flow nasal cannula or face mask O2 with FiO2 ≥ 0.5 for ≥4 hours
  • use of vasopressors for shock of any etiology for >1 hour
Show all 10Show fewer
  • Both participant and ICU patient must be adult (age ≥18 years of age)
  • Participant must be able to read, speak, and write in English
  • Participant must be enrolled within 72 hours of the patient's meeting mechanical ventilation criteria
  • Participants who live with the patient will be accorded higher priority than those who do not live with the patient because they are more likely to be involved as caregivers. The preference would be for the participant to be the designated power of attorney; if there is no designated power of attorney living with the patient, then the primary informal caregiver (identified either by the patient or by the family) would be enrolled; if either of these is not available, the default surrogate (defined in figure 1) would be enrolled. If no one living with the patient meets these criteria, then family members and informal caregivers not living with the patient will be screened for the study. The preference would again be for first, the designated power of attorney, then a primary caregiver and a default surrogate. An informal caregiver provides care without reimbursement.

Who cannot join

  • Pregnant or breastfeeding females
  • Prisoners
  • Children (age <18 years of age)
  • Known history of PTSD, dementia, or schizophrenia. Presence of these illnesses will be per participant report of physician diagnosis and treatment
  • If a patient has been transferred from another ICU after an ICU course greater than 24 hours, or if the patient has had a previous ICU or long term acute care (LTAC) admission in the last 90 days, the family member or caregiver will be excluded.
  • Patients admitted for hospice
  • Participants who live more than 200 miles away or who have no specified domicile
  • Non-English speaking

Trial locations and contacts

1 site in 1 country.

Ramona Hopkins, PhD contact

(801) 507-4569

mona.hopkins@imail.org

United States1 site, 1 recruiting
  • Intermountain Medical Center

    Murray, Utah, 84107

    Mardee Merrill, 801-507-4608, Mardee.Merill@imail.org

    Valerie Aston, (801) 507-4606, valerie.aston@imail.org

    Recruiting

Other trials in United States

About this study

Official title: ICU Experience Among Family Members of ICU Patients

The ICU is a stressful and challenging place for patients and their families. Many family members experience anxiety, depression, and post-traumatic stress disorder during and after their ICU experience. The investigators are studying post-traumatic growth in this study. Post-traumatic growth (PTG) is a set of positive changes that occurs after a challenging or difficult life experience. This study investigates the effects of expressive writing on positive changes that occur after a difficult experience. PTG will be compared between the intervention group receiving the expressive writing intervention and the control group (non-expressive or fact based writing).

Being tested
Expressive writing, Control writing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Expressive writingBehavioural

    Brief expressive writing intervention

  • Control writingBehavioural

    Brief fact-based writing exercise.

Study groups in NCT02940028
Study groupRoleWhat they receive
Expressive writing interventionExperimentalThe intervention group will participate in a brief expressive writing intervention.
Receives: Behavioral: Expressive writing
Control writing interventionOtherThe control group will receive a control writing condition (fact based writing).
Receives: Behavioral: Control writing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Posttraumatic Growth Inventory

    Measured: 4 months

Secondary outcomes (8)
  1. Hospital Depression and Anxiety Scale

    Measured: 4 months

  2. Impact of Event Scale Revised (IES-R)

    Measured: 4 months

  3. Perceived Stress Scale

    Measured: 4 months

  4. Brief COPE

    Measured: 4 months

  5. Physical Symptoms Scale

    Measured: 4 months

  6. Groningen Activity Restriction Scale (GARS)

    Measured: 4 months

  7. Activity Restriction Scale

    Measured: 4 months

  8. Essay Evaluation Measure

    The essay evaluation measure assesses if the writing sample (essay) was personal, meaningful and reveals emotions. This measure has 3 items that are scored 0 to 6 for a total score of 0 to 18.

    Measured: 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Oct 2016 (estimated)
  2. Study start29 Apr 2017
  3. Primary completionDec 2020 (estimated)
  4. Study completionApr 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
130 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02940028
Sponsor's protocol ID
1050308
Status last verified
Jun 2020
First submitted
12 Oct 2016
Last updated
18 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Expressive writing in people with Post-Traumatic Growth, Psychological, run by Intermountain Health Care, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mardee Merrill (801-507-4608, mardee.merrill@imail.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Posttraumatic Growth Inventory (time frame: 4 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in